Valirix plc develop treatments of oncology and womens health to improve patients lives. They provide financial, scientific and commercial framework to enable a rapid translation of innovative science into clinical development.
Industry: | Health Care |
Sector: | Health Care |
Website: | www.valirx.com |
Twitter: | @valirxplc |
Exchange: | LSE |
Admission date: | 5 Apr 2020 |
Market: | Aim |
Region: | Europe |
14 Jun 2023 | Shareholders Presentation and Q&A Session |
5 Jun 2023 | Audited Results |
8 Mar 2023 | Investor Webinar |
2 Feb 2023 | General Meeting |
31 Aug 2022 | Half-year Report |